Table 1.
Baseline patient characteristics and long-term outcomes
| n | 40 |
| Gender | |
| F | 11 (27.5) |
| M | 29 (72.5) |
| Age | 1.4 [0.8, 3.3] |
| Indication for LT | |
| Biliary atresia | 24 (60.0) |
| Liver cirrhosis–fibrosis | 5 (12.5) |
| Malignancy | 4 (10.0) |
| Alagille syndrome | 3 (7.5) |
| Inborn error of metabolism | 2 (5.0) |
| Primary hyperoxaluria type I | 1 (2.5) |
| Wilson | 1 (2.5) |
| Type of graft | |
| Deceased donor—whole | 19 (47.5) |
| Deceased donor—LLS | 16 (40.0) |
| Living donor—LLS | 5 (12.5) |
| Combined liver–kidney transplant | 3 (7.5) |
| Re-LT | 10 (25.0) |
| Number of transplants | |
| 1 | 30 (75.0) |
| 2 | 8 (20.0) |
| 3 | 2 (5.0) |
| Maintenance IS | |
| BID Tac | 7 (18.4) |
| BID Tac + MMF | 2 (5.3) |
| BID Tac + prednisone | 2 (5.3) |
| CyA | 3 (7.9) |
| MMF | 3 (7.9) |
| None | 1 (2.6) |
| OD Tac | 15 (39.5) |
| OD Tac + MMF | 4 (10.5) |
| OD Tac + prednisone | 1 (2.6) |
| Scholarity | |
| University diploma or higher | 12 (32.4) |
| High school | 19 (51.4) |
| Middle school | 2 (5.4) |
| None | 4 (10.8) |
| Working or in education | 30 (81.1) |
| Had children | 7 (17.5) |
| Practice sport | 14 (35.0) |
Data are expressed as number (counts) or median (interquartile range)
LLS left lateral sector, LT liver transplantation, BID bis in die, Tac tacrolimus, MMF mycophenolate mofetil, CyA cyclosporin A, OD once daily